| |
| |
|
| Insider
Information: |
Kanesa-Thasan Niranjan |
| Relationship: |
|
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Icosavax, Inc. |
ICVX |
|
2024-02-19 |
0 |
2021-08-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ICVX |
Icosavax, Inc. |
See Remarks |
– – – |
2024-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(223,980) |
0 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
Chief Medical Officer |
• – – |
2023-12-20 |
4 |
AS |
$15.46 |
$183,692 |
D/D |
(11,884) |
223,980 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
Chief Medical Officer |
• – – |
2023-07-31 |
4 |
AS |
$8.86 |
$29,447 |
D/D |
(3,323) |
235,864 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
Chief Medical Officer |
• – – |
2023-02-13 |
4 |
AS |
$10.69 |
$19,183 |
D/D |
(1,794) |
239,187 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
Chief Medical Officer |
• – – |
2023-01-04 |
4 |
S |
$15.70 |
$1,670,460 |
D/D |
(106,373) |
223,980 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
Chief Medical Officer |
• – – |
2023-01-04 |
4 |
OE |
$0.84 |
$249,298 |
D/D |
106,373 |
330,353 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
Chief Medical Officer |
• – – |
2022-08-02 |
4 |
AS |
$6.70 |
$3,640 |
D/D |
(543) |
239,314 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
Chief Medical Officer |
• – – |
2022-08-01 |
4 |
AS |
$6.64 |
$13,281 |
D/D |
(2,001) |
239,857 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
Chief Medical Officer |
• – – |
2022-07-29 |
4 |
AS |
$7.11 |
$4,982 |
D/D |
(701) |
241,858 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
Chief Medical Officer |
• – – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
19,485 |
242,559 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
Chief Medical Officer |
• – – |
2022-02-02 |
4 |
OE |
$0.84 |
$52,101 |
D/D |
52,752 |
221,408 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
Chief Medical Officer |
• – – |
2021-08-02 |
4 |
B |
$15.00 |
$99,990 |
D/D |
6,666 |
6,666 |
2.74 |
- |
|
| ICVX |
Icosavax, Inc. |
Chief Medical Officer |
• – – |
2021-07-30 |
4 |
A |
$15.00 |
$622,500 |
D/D |
41,500 |
168,656 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
